Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Collins

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
ClobazamYu-tze Ng, Stephen D Collins
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
VigabatrinJames W Wheless, R Eugene Ramsay, Stephen D Collins
Epilepsy Research|February 11, 2003
Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulationSandeep Dutta, James C Cloyd, G Richard Granneman, et al.
Frontiers in Pharmacology|November 2, 2016
Huperzine A Provides Robust and Sustained Protection against Induced Seizures in <i>Scn1a</i> Mutant MiceJennifer C Wong, Stacey B B Dutton, Stephen D Collins, et al.
Epilepsy Research|February 11, 2003
Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsyJames C Cloyd, Sandeep Dutta, Guoliang Cao, et al.
Journal of Child Neurology|April 21, 2010
Vigabatrin for the treatment of infantile spasms: final report of a randomized trialRoy D Elterman, W Donald Shields, Richard M Bittman, et al.
Gut|December 17, 2010
Panhematin provides a therapeutic benefit in experimental pancreatitisAida Habtezion, Raymond Kwan, Ehsaan Akhtar, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 23, 2010
Heme oxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: a potential therapeutic targetAida Habtezion, Raymond Kwan, Alice L Yang, et al.
Brain, Behavior, and Immunity|August 18, 2020
Targeted interleukin-10 plasmid DNA therapy in the treatment of osteoarthritis: Toxicology and pain efficacy assessmentsLinda R Watkins, Raymond A Chavez, Robert Landry, et al.
Epilepsia|August 6, 2013
Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy developmentTerence J O'Brien, Elinor Ben-Menachem, Edward H Bertram, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
ClobazamYu-tze Ng, Stephen D Collins
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
VigabatrinJames W Wheless, R Eugene Ramsay, Stephen D Collins
Epilepsy Research|February 11, 2003
Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulationSandeep Dutta, James C Cloyd, G Richard Granneman, et al.
Frontiers in Pharmacology|November 2, 2016
Huperzine A Provides Robust and Sustained Protection against Induced Seizures in <i>Scn1a</i> Mutant MiceJennifer C Wong, Stacey B B Dutton, Stephen D Collins, et al.
Epilepsy Research|February 11, 2003
Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsyJames C Cloyd, Sandeep Dutta, Guoliang Cao, et al.
Journal of Child Neurology|April 21, 2010
Vigabatrin for the treatment of infantile spasms: final report of a randomized trialRoy D Elterman, W Donald Shields, Richard M Bittman, et al.
Gut|December 17, 2010
Panhematin provides a therapeutic benefit in experimental pancreatitisAida Habtezion, Raymond Kwan, Ehsaan Akhtar, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 23, 2010
Heme oxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: a potential therapeutic targetAida Habtezion, Raymond Kwan, Alice L Yang, et al.
Brain, Behavior, and Immunity|August 18, 2020
Targeted interleukin-10 plasmid DNA therapy in the treatment of osteoarthritis: Toxicology and pain efficacy assessmentsLinda R Watkins, Raymond A Chavez, Robert Landry, et al.
Epilepsia|August 6, 2013
Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy developmentTerence J O'Brien, Elinor Ben-Menachem, Edward H Bertram, et al.
Pageof 2